1. Home
  2. EYPT vs NX Comparison

EYPT vs NX Comparison

Compare EYPT & NX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYPT
  • NX
  • Stock Information
  • Founded
  • EYPT N/A
  • NX 1927
  • Country
  • EYPT
  • NX United States
  • Employees
  • EYPT N/A
  • NX N/A
  • Industry
  • EYPT Biotechnology: Laboratory Analytical Instruments
  • NX Metal Fabrications
  • Sector
  • EYPT Industrials
  • NX Industrials
  • Exchange
  • EYPT Nasdaq
  • NX Nasdaq
  • Market Cap
  • EYPT 741.0M
  • NX 852.8M
  • IPO Year
  • EYPT N/A
  • NX N/A
  • Fundamental
  • Price
  • EYPT $14.01
  • NX $18.18
  • Analyst Decision
  • EYPT
  • NX Strong Buy
  • Analyst Count
  • EYPT 0
  • NX 1
  • Target Price
  • EYPT N/A
  • NX $38.00
  • AVG Volume (30 Days)
  • EYPT 659.8K
  • NX 429.0K
  • Earning Date
  • EYPT 08-06-2025
  • NX 09-04-2025
  • Dividend Yield
  • EYPT N/A
  • NX 1.76%
  • EPS Growth
  • EYPT N/A
  • NX N/A
  • EPS
  • EYPT N/A
  • NX N/A
  • Revenue
  • EYPT $51,898,000.00
  • NX $1,839,956,000.00
  • Revenue This Year
  • EYPT N/A
  • NX $49.00
  • Revenue Next Year
  • EYPT N/A
  • NX $2.99
  • P/E Ratio
  • EYPT N/A
  • NX N/A
  • Revenue Growth
  • EYPT 2.99
  • NX 70.18
  • 52 Week Low
  • EYPT $3.91
  • NX $15.30
  • 52 Week High
  • EYPT $14.37
  • NX $32.23
  • Technical
  • Relative Strength Index (RSI)
  • EYPT 77.25
  • NX 36.13
  • Support Level
  • EYPT $11.38
  • NX $20.00
  • Resistance Level
  • EYPT $12.24
  • NX $21.21
  • Average True Range (ATR)
  • EYPT 0.74
  • NX 0.81
  • MACD
  • EYPT 0.13
  • NX -0.33
  • Stochastic Oscillator
  • EYPT 89.80
  • NX 24.41

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.

About NX Quanex Building Products Corporation

Quanex Building Products Corp is a manufacturer of components sold to original equipment manufacturers in the building products industry. It manufactures engineered products like window and door components that include flexible insulating glass spacers, extruded vinyl profiles, window and door screens, solar panel sealants and precision-formed metal and wood products among others. Its four operating segments are North American Fenestration being the key revenue driver, European Fenestration, North American Cabinet Components, and Tyman. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: